From a data perspective, recent studies have focused on exploring effective targets for AD (Chong et al., 2021); some genes, including oncogenes and suppressor genes, have been found, such as β-secretase 1 (BACE1) (Dai et al., 2021) and receptor-interacting protein kinase 1 (RIPK1) (Li et al., 2021). This evidence concerns the gene BACE1 and Alzheimer disease.